Press Release Archives

Press Release

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Certara to report third quarter 2025 financial results on November 6th, 2025. Company management to…

CertaraOctober 10, 2025

Press Release

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Pinnacle 21® Enterprise Plus delivers a 50% reduction in time spent drafting mapping specifications, according…

CertaraSeptember 4, 2025

Press Release

Certara to Participate in Upcoming Investor Conferences

RADNOR, PA – September 2, 2025 -- Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraSeptember 2, 2025

Press Release

Certara Reports Second Quarter 2025 Financial Results

RADNOR, PA— August 6, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…

CertaraAugust 6, 2025

Press Release

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara announces that EMA has formally qualified the Simcyp® Simulator for use in regulatory submissions…

CertaraAugust 4, 2025

Press Release

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Strengthening technology innovation and leadership of the Certara AI/ML-enabled biosimulation platform used to speed time…

CertaraJuly 31, 2025

Press Release

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

July 9, 2025 Radnor, Pa. — July 9, 2025 -- Certara, Inc. (Nasdaq: CERT), a…

CertaraJuly 9, 2025

Press Release

Certara Announces Expansion of Clinical Technology Collaboration with Merck

July 8, 2025RADNOR, PA – July 8, 2025 – Certara, Inc. (Nasdaq: CERT), a global…

CertaraJuly 8, 2025

Press Release

Certara Reports First Quarter 2025 Financial Results

RADNOR, PA— May 5, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…

CertaraMay 5, 2025

Press Release

Certara to Participate in Upcoming Investor Conferences

RADNOR, PA — April 29, 2025 -- Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraApril 29, 2025

Press Release

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Certara to Participate in Upcoming Investor Conferences

Certara Reports Second Quarter 2025 Financial Results

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Certara Announces Expansion of Clinical Technology Collaboration with Merck

Certara Reports First Quarter 2025 Financial Results

Certara to Participate in Upcoming Investor Conferences

Newsletter sign up

Quick links

Solutions

Contact